Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Dec 2003

Peshkin Beth N, Isaacs Claudine, Finch Clinton, Kent Sheryl, Schwartz Marc D

Abstract excerpt

PURPOSE: To assess physician recommendations about the use of tamoxifen in premenopausal BRCA1 and BRCA2 mutation carriers. METHODS: We mailed surveys to a stratified random sample of 1,286 physicians selected from the San Antonio Breast Cancer Symposium mailing list. Eligible participants were physicians whose practice consisted of >/= 10% breast cancer patients. Participants were asked to complete a three-part,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Data Collection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Making

Share to Health Knowledge, Attitudes, Practice

Share to Pilot Projects

Share to Practice Patterns, Physicians'

Share to Receptors, Estrogen

Share to Tamoxifen

Source

Identifiers

PMID: 14645421
DOI: 10.1200/JCO.2003.02.107

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.PMID 14645421Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.Semantic proximity Read ↗

Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.Semantic proximity Read ↗

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.Semantic proximity Read ↗

Physicians' experiences with BRCA1/2 testing in community settings.Semantic proximity Read ↗

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.